-
Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?
Tuesday, February 23, 2016 - 1:30pm | 320Slingshot Insights recently conducted an interview with Dr. Ashwin Balagopal, assistant professor of medicine at the Johns Hopkins University School of Medicine about the impact that Dynavax Technologies Corporation (NASDAQ: DVAX)’s HBV-23 will have on the HBV vaccine market, particularly...